To assess the effectiveness of Systane COMPLETE in improving meibomian gland score and in reducing symptoms of ocular dryness.

ABSTRACT:

Purpose

To assess the effectiveness of Systane COMPLETE in reducing symptoms of ocular dryness and improving Meibomian Gland (MG) Score in subjects with mild to moderate dry eye disease (DED).

Methods

A prospective, interventional, single-center, single-arm study was conducted including cases of mild to moderate DED. Participants were prescribed a topical lipid-based combination of propylene glycol (PG) and hydroxypropyl guar (HPG) (Systane^® COMPLETE), administered four times daily for 30 days. Dry eye assessment parameters, Meibo score, and Ocular Surface Disease Index (OSDI) questionnaire responses were obtained before and after treatment.

Results

A total of 105 cases with mild to moderate DED were included in the study. Statistically significant improvem

SUBMITTER: Sharma N 

PROVIDER: S-EPMC12631756 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature